|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 57.57M 4.45M 4.17M 3.81M 7.19M 497M 7.27M 49.27M 19.17M 250M 19.51M 19.09M 827M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 116M 8.96M 8.38M 7.66M 14.46M 1B 14.61M 99.05M 38.54M 502M 39.22M 38.37M 1.66B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| -0.67% | +5.66% | +75.21% | +125.34% | 1,119B | |
| +1.04% | +4.87% | +52.29% | +65.95% | 651B | |
| -0.17% | +6.04% | +25.60% | +79.85% | 468B | |
| -1.38% | +4.31% | +41.64% | +41.08% | 374B | |
| -0.52% | +3.53% | +24.32% | +40.27% | 302B | |
| -1.06% | +5.67% | +1.19% | +12.44% | 259B | |
| +1.03% | +6.90% | +51.11% | +72.46% | 238B | |
| -0.53% | +1.54% | -17.77% | -54.10% | 208B | |
| +0.42% | +6.06% | +27.86% | +90.47% | 181B | |
| Average | -0.26% | +5.17% | +31.27% | +52.64% | 379.99B | |
| Weighted average by Cap. | -0.15% | +5.40% | +43.93% | +72.03% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 98.53M 7.62M 7.13M 6.52M 12.31M 851M 12.44M 84.32M 32.81M 427M 33.39M 32.66M 1.41B | 9.91M 110M 8.5M 7.95M 7.27M 13.71M 949M 13.86M 93.96M 36.56M 476M 37.21M 36.4M 1.58B |
| Net income | 665K 7.37M 570K 534K 488K 920K 63.67M 930K 6.31M 2.45M 31.97M 2.5M 2.44M 106M | 762K 8.44M 653K 611K 559K 1.05M 72.91M 1.07M 7.22M 2.81M 36.61M 2.86M 2.8M 121M |
| Net Debt | 4.15M 45.95M 3.56M 3.33M 3.04M 5.74M 397M 5.8M 39.32M 15.3M 199M 15.57M 15.23M 660M | 5.25M 58.17M 4.5M 4.21M 3.85M 7.27M 503M 7.34M 49.78M 19.37M 252M 19.71M 19.28M 835M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
